HemaSphere (Jun 2022)
S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMA
- M. C. Pirosa,
- A. Bruscaggin,
- L. Terzi di Bergamo,
- M. Salehi,
- K. Pini,
- V. Spina,
- S. Bocchetta,
- A. Condoluci,
- G. Forestieri,
- D. Piffaretti,
- J. Marques De Almeida,
- S. Annunziata,
- F. Bergesio,
- E. Borsatti,
- P. Bulian,
- S. Chauvie,
- C. Marco,
- D. T. Martina,
- G. Bernhard,
- M. Kurlapski,
- A. Moccia,
- R. Moia,
- A. Rinaldi,
- M. Rodari,
- G. Romanowicz,
- G. M. Sacchetti,
- A. Stasia,
- A. Stathis,
- G. Stüssi,
- I. Zangrilli,
- L. M. Larocca,
- A. Pinto,
- A. Santoro,
- F. Cavalli,
- E. Zucca,
- V. Gattei,
- J. M. Zaucha,
- C. Carlo-Stella,
- S. Hohaus,
- G. Gaidano,
- L. Ceriani,
- D. Rossi
Affiliations
- M. C. Pirosa
- 1 Division of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
- A. Bruscaggin
- 1 Division of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
- L. Terzi di Bergamo
- 1 Division of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
- M. Salehi
- 1 Division of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
- K. Pini
- 1 Division of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
- V. Spina
- 1 Division of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
- S. Bocchetta
- 1 Division of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
- A. Condoluci
- 1 Division of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
- G. Forestieri
- 1 Division of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
- D. Piffaretti
- 1 Division of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
- J. Marques De Almeida
- 1 Division of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
- S. Annunziata
- 2 Institute of Nuclear Medicine, Policlinico Gemelli Foundation, Catholic University of the Sacred Heart, Rome
- F. Bergesio
- 3 Department of Medical Physics, Santa Croce e Carle Hospital, Cuneo
- E. Borsatti
- 4 Nuclear Medicine, IRCCS CRO
- P. Bulian
- 5 Clinical and Experimental Onco Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy
- S. Chauvie
- 3 Department of Medical Physics, Santa Croce e Carle Hospital, Cuneo
- C. Marco
- 6 Clinic of Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland
- D. T. Martina
- 7 Humanitas Cancer Center, Humanitas Clinical and Research Center, Milan, Italy
- G. Bernhard
- 8 Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
- M. Kurlapski
- 9 Department of Hematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland
- A. Moccia
- 10 Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
- R. Moia
- 11 Division of hematology, University of Eastern Piedmont, Novara, Italy
- A. Rinaldi
- 12 Genomics Facility, Institute of Oncology Research, Bellinzona, Switzerland
- M. Rodari
- 13 Unit of Nuclear Medicine, Humanitas Clinical and Research Center, Milan, Italy
- G. Romanowicz
- 14 Department of Nuclear Medicine, Medical University of Gdańsk, Gdańsk, Poland
- G. M. Sacchetti
- 15 Nuclear Medicine, “Maggiore della Carità ” Hospital, Novara
- A. Stasia
- 8 Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
- A. Stathis
- 10 Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
- G. Stüssi
- 8 Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
- I. Zangrilli
- 16 Department of diagnostic imaging, oncological radiotherapy and hematology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- L. M. Larocca
- 17 Division of Pathology, Policlinico Gemelli Foundation, Catholic University of the Sacred Heart, Rome
- A. Pinto
- 18 Hematology‐Oncology and Stem Cell transplantation Unit, National Cancer Institute, Fondazione “G. Pascale” IRCCS, Naples
- A. Santoro
- 7 Humanitas Cancer Center, Humanitas Clinical and Research Center, Milan, Italy
- F. Cavalli
- 1 Division of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
- E. Zucca
- 10 Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
- V. Gattei
- 19 Clinical and Experimental Onco Hematology Unit, IRCCS CRO, Aviano, Italy
- J. M. Zaucha
- 9 Department of Hematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland
- C. Carlo-Stella
- 7 Humanitas Cancer Center, Humanitas Clinical and Research Center, Milan, Italy
- S. Hohaus
- 16 Department of diagnostic imaging, oncological radiotherapy and hematology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- G. Gaidano
- 11 Division of hematology, University of Eastern Piedmont, Novara, Italy
- L. Ceriani
- 6 Clinic of Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland
- D. Rossi
- 1 Division of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
- DOI
- https://doi.org/10.1097/01.HS9.0000843792.32037.28
- Journal volume & issue
-
Vol. 6
pp. 126 – 127
Abstract
No abstracts available.